Last reviewed · How we verify
NCT03203148
Two Monitors for Measuring the Activated Clotting Time: A Comparison
trial testing Point-of-Care ACT in Cardiopulmonary Bypass in 20 participants. Completed in 1 November 2017.
1 October 2017
Quick facts
| Lead sponsor | Umeå University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 18 April 2017 |
| Primary completion | 1 October 2017 |
| Estimated completion | 1 November 2017 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Point-of-Care ACT
Conditions studied
- Cardiopulmonary Bypass — all drugs for Cardiopulmonary Bypass →
- Blood Coagulation — all drugs for Blood Coagulation →
- Point-of-Care Testing — all drugs for Point-of-Care Testing →
Sponsor
Umeå University
Who can join
Adults 20 to 80, any sex, with Cardiopulmonary Bypass or Blood Coagulation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this observational study a comparison is made between two different monitors for measurement of the activated clotting time (ACT): mechanical versus biochemical techniques
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03203148
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiopulmonary Bypass
Currently open trials in the same condition.
- NCT07390903 — GLS in Difficult CPB Weaning · recruiting
- NCT07193719 — Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children · Phase 1, PHASE2 · recruiting
- NCT07354841 — Safety and Performance Evaluation of CPB Venous and Arterial Cannulas · NA · recruiting
- NCT07267546 — Heart-Lung Machine: Impact of the Priming Solution on Acid-Base Balance, Electrolytes and Outcome on Patients Undergoing · NA · recruiting
- NCT06702553 — Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass · Phase 3 · recruiting
Other Umeå University trials
Trials by the same sponsor.
- NCT07407946 — Blended Trauma-Focused Cognitive Behavioral Therapy With Compassion · NA · recruiting
- NCT07346820 — VDJ-recombination of the B-cell Receptor Following Hematopoietic Stem Cell Transplantation · not yet recruiting
- NCT07417358 — Single-Stapled Technique for Colorectal Anastomosis · recruiting
- NCT07316426 — Preoptimisation in Ventral Hernia Surgery · NA · recruiting
- NCT07170722 — Sub-threshold DRG Stimulation vs Sham in Established Responders · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03203148 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Umeå University
- Last refreshed: 12 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03203148.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing